Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR)

CUSIP: 49372L100

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
-5,508,473
Put/Call ratio
0.45%
SEC-reported price per share
$0.95
Number of holders
81
Value change
-$6,015,885
Number of buys
40
Open additional details 1 more signal available
Number of sells
38
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,393,623

Security key

49372L100

Report period

Q4 2023

Institutions

81

Top holders

10

Ownership snapshot

Top reported holders of KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Morningside Venture Inves...
Disclosed value leader
MONTANOVA CAPITAL, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $8,529,433 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MONTANOVA CAPITAL, LLC has the largest disclosed position value at $8.53M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MONTANOVA CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
Morningside Venture Investments Ltd $1.75M
MONTANOVA CAPITAL, LLC $8.53M
Avidity Partners Management LP $7.15M
ORBIMED ADVISORS LLC $6.5M
BlackRock Finance, Inc. $5.89M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Morningside Venture Investments Ltd
3/4/5
10%+ Owner
—
denominator unverified
$1,753,194
1,947,993 shares
— 15 Aug 2023
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$8,529,433
7,167,591 shares
— 30 Sep 2023
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$7,153,209
6,011,100 shares
— 30 Sep 2023
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$6,500,970
5,463,000 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$5,893,226
4,952,290 shares
— 30 Sep 2023
Prosight Management, LP
13F
Company
13F
—
denominator unverified
$5,677,251
4,770,799 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
81
Shares
49,383,993
Rows available
81
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q4 2023 holders
81
Holder diff
80
Investor Q3 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2025 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .